Patient and Provider Perspectives on Genetic Risk Profiling
ConditionProstate Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age18-100
SponsorRoyal Marsden NHS Foundation Trust
About this trial
A qualitative interview study exploring the patient and provider perspectives on the clinical utility of genetic risk profiling in routine clinical practice. The findings from the study may contribute towards future research and informing clinical practice.
Eligibility criteria
Qualifiers
Individuals assigned male at birth who are aged 18 and over and who have capacity to consent
Patients who have undergone genetic risk profiling for prostate cancer and have received their results
Individuals from diverse backgrounds (age, ethnicity, risk status, etc)
Healthcare providers who have delivered a genetic risk profiling result for prostate cancer
Disqualifiers
Individuals who lack capacity to consent
Individuals deemed unsuitable to recruit based on their poor performance status or current medical condition
Trial design
Treatments tested in this trial
- Qualitative interview
Treatment groups
40 Participants
are divided into 2 treatment groupsSponsors and collaborators
Royal Marsden NHS Foundation Trust
Lead sponsor
Institute of Cancer Research, United Kingdom
Collaborator
Source ClinicalTrials.gov